StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5299
This month
77
This week
25
This year
441
Today
3
Yesterday
6
Publishing Date
2024 - 04 - 17
7
2024 - 04 - 16
5
2024 - 04 - 15
7
2024 - 04 - 11
7
2024 - 04 - 10
8
2024 - 04 - 09
8
2024 - 04 - 08
4
2024 - 04 - 04
7
2024 - 04 - 02
7
2024 - 04 - 01
4
2024 - 03 - 28
8
2024 - 03 - 27
4
2024 - 03 - 26
7
2024 - 03 - 25
8
2024 - 03 - 22
4
2024 - 03 - 21
6
2024 - 03 - 20
5
2024 - 03 - 19
11
2024 - 03 - 18
6
2024 - 03 - 15
6
2024 - 03 - 13
8
2024 - 03 - 12
8
2024 - 03 - 11
6
2024 - 03 - 08
4
2024 - 03 - 07
4
2024 - 03 - 06
6
2024 - 03 - 05
10
2024 - 03 - 04
14
2024 - 03 - 01
4
2024 - 02 - 29
8
2024 - 02 - 28
6
2024 - 02 - 26
5
2024 - 02 - 23
8
2024 - 02 - 20
10
2024 - 02 - 15
4
2024 - 02 - 14
8
2024 - 02 - 13
8
2024 - 02 - 12
9
2024 - 02 - 09
5
2024 - 02 - 08
5
2024 - 02 - 06
6
2024 - 02 - 05
5
2024 - 02 - 01
8
2024 - 01 - 30
8
2024 - 01 - 29
6
2024 - 01 - 26
5
2024 - 01 - 25
8
2024 - 01 - 24
6
2024 - 01 - 23
4
2024 - 01 - 22
10
2024 - 01 - 19
5
2024 - 01 - 18
5
2024 - 01 - 17
6
2024 - 01 - 16
8
2024 - 01 - 10
4
2024 - 01 - 09
7
2024 - 01 - 08
11
2024 - 01 - 04
6
2024 - 01 - 03
5
2024 - 01 - 02
5
Sector
Administrative and support and waste management and remediation services
1
Commercial services
2
Communications
8
Consumer non-durables
1
Consumer services
2
Distribution services
4
Electronic technology
3
Finance
28
Finance and insurance
1
Health care and social assistance
1
Health services
2
Health technology
294
Industrial services
4
Manufacturing
40
Mining, quarrying, and oil and gas extraction
1
N/a
21
Non-energy minerals
2
Process industries
3
Producer manufacturing
8
Professional, scientific, and technical services
6
Technology services
6
Utilities
1
Wholesale trade
2
Tags
Acquisition
687
Advanced
218
Agreement
489
America
217
Biopharma
226
Business
919
Cancer
350
Ceo
302
Companies
245
Company
515
Conference
2501
Corporation
794
Deadline
504
Distribution
228
Earnings
245
Energy
704
Events
293
Fda
349
Financial
3139
First
1699
For
677
Global
1513
Grants
246
Group
789
Growth
1008
Health
455
International
390
Key
397
Life
250
Management
383
Market
2674
Medical
378
Meeting
558
Million
1224
N/a
28403
Nasdaq
533
Offering
650
One
248
Partnership
310
Pharma
222
Pharmaceuticals
588
Platform
281
Program
422
Reach
492
Report
1914
Research
833
Results
4328
Revenue
276
Services
401
Set
327
Solutions
426
Spac
230
Study
357
System
286
Technology
611
Therapeutics
1191
Treatment
441
Trial
440
Update
909
Year
2883
Entities
4d molecular therapeutics inc
3
Abbott laboratories
13
Abbvie inc.
4
Abvc biopharma inc
2
Akebia therapeutics, inc.
2
Amgen inc.
4
Angiodynamics, inc.
2
Apogee therapeutics, inc.
3
Applied therapeutics, inc.
3
Arvinas, inc.
2
Astellas pharma inc
8
Astrazeneca plc
3
Atossa therapeutics, inc.
2
Axsome therapeutics, inc.
2
Ayala pharmaceuticals, inc.
2
Bausch health companies inc.
2
Becton, dickinson and company
2
Beigene, ltd.
2
Biogen inc.
4
Bristol-myers squibb company
8
Citius pharmaceuticals, inc.
3
Clearmind medicine inc.
4
Clene inc
4
Eli lilly and company
9
Eyenovia, inc.
3
Femasys inc
4
Fibrobiologics inc.
4
Gilead sciences, inc.
3
Glaxosmithkline plc
6
Hutchison china meditech limited
3
Johnson & johnson
28
Koninklijke philips n.v.
3
Madrigal pharmaceuticals, inc.
3
Maia biotechnology, inc.
3
Medies
3
Medtronic plc
4
Merck & company, inc.
3
Neurobo pharmaceuticals, inc.
6
Neuronetics, inc.
3
Novartis ag
7
Novo nordisk a/s
5
Nrx pharmaceuticals inc
4
Oncternal therapeutics, inc.
3
Orange
8
Pepgen inc.
3
Perrigo company
8
Pfizer, inc.
4
Precision biosciences, inc.
4
Regeneron pharmaceuticals, inc.
6
Sanofi
38
Tenax therapeutics, inc.
3
Teva pharmaceutical industries ltd
3
Tg therapeutics, inc.
5
Travere therapeutics inc.
5
Ultragenyx pharmaceutical inc.
5
Vanda pharmaceuticals inc.
4
Vertex pharmaceuticals incorporated
9
Virios therapeutics inc
3
Xylem inc.
4
Zevra therapeutics, inc.
3
Symbols
ABBV
4
ABT
13
ABVC
2
AKBA
2
ALPMF
8
ALPMY
8
AMGN
4
ANGO
2
APGE
3
APLT
3
AQUA
2
ARVN
2
AZN
3
AZNCF
3
BIIB
4
BMY
8
CLNN
4
CMND
4
CTXR
3
DTIL
4
EYEN
3
FBLG
4
FDMT
3
FEMY
4
FNCTF
8
GILD
3
GLAXF
6
GSK
6
HCM
3
JNJ
28
LLY
9
MAIA
3
MDGL
3
MDT
4
MEDE
3
MRK
3
NRBO
6
NRXP
4
NVO
5
NVS
7
NVSEF
6
ONCT
3
PEPG
3
PFE
4
PHG
3
PRGO
8
RARE
5
REGN
6
SNY
38
SNYNF
38
STIM
3
TENX
3
TEVJF
3
TGTX
5
TVTX
5
VIRI
3
VNDA
4
VRTX
9
XYL
4
ZVRA
3
Exchanges
Amex
7
Nasdaq
369
Nyse
106
Crawled Date
2024 - 04 - 17
7
2024 - 04 - 16
5
2024 - 04 - 15
7
2024 - 04 - 11
7
2024 - 04 - 10
8
2024 - 04 - 09
8
2024 - 04 - 08
4
2024 - 04 - 04
7
2024 - 04 - 02
7
2024 - 04 - 01
5
2024 - 03 - 28
9
2024 - 03 - 26
7
2024 - 03 - 25
8
2024 - 03 - 22
4
2024 - 03 - 21
6
2024 - 03 - 20
5
2024 - 03 - 19
12
2024 - 03 - 18
5
2024 - 03 - 15
6
2024 - 03 - 13
9
2024 - 03 - 12
7
2024 - 03 - 11
6
2024 - 03 - 08
4
2024 - 03 - 07
4
2024 - 03 - 06
6
2024 - 03 - 05
11
2024 - 03 - 04
13
2024 - 03 - 01
4
2024 - 02 - 29
8
2024 - 02 - 28
6
2024 - 02 - 26
5
2024 - 02 - 23
8
2024 - 02 - 20
9
2024 - 02 - 14
8
2024 - 02 - 13
8
2024 - 02 - 12
9
2024 - 02 - 09
5
2024 - 02 - 08
6
2024 - 02 - 06
6
2024 - 02 - 05
5
2024 - 02 - 01
8
2024 - 01 - 31
3
2024 - 01 - 30
8
2024 - 01 - 29
6
2024 - 01 - 26
5
2024 - 01 - 25
8
2024 - 01 - 24
6
2024 - 01 - 23
4
2024 - 01 - 22
10
2024 - 01 - 19
5
2024 - 01 - 18
5
2024 - 01 - 17
6
2024 - 01 - 16
8
2024 - 01 - 10
4
2024 - 01 - 09
8
2024 - 01 - 08
10
2024 - 01 - 05
3
2024 - 01 - 04
5
2024 - 01 - 03
5
2024 - 01 - 02
5
Crawled Time
00:00
13
00:20
1
01:00
6
02:00
6
03:00
1
04:00
2
04:20
2
05:00
5
06:00
4
07:00
2
08:00
6
09:00
4
10:00
3
11:00
29
12:00
69
12:30
33
13:00
61
13:30
18
14:00
24
14:30
15
15:00
10
15:30
12
16:00
4
16:20
2
17:00
10
18:00
6
19:00
6
20:00
19
21:00
27
22:00
17
23:00
24
Source
apyxmedical.com
1
bridgebio.com
1
broadstone.com
1
spacfeed.com
1
www.biospace.com
116
www.globenewswire.com
200
www.prnewswire.com
120
www.xortx.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This year
tags :
Treatment
save search
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published:
2024-04-19
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
0.0%
|
O:
-0.13%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
0.0%
|
O:
0.79%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
0.0%
|
O:
-0.75%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.0%
|
O:
0.82%
H:
0.0%
C:
0.0%
first
treatment
for
Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published:
2024-04-19
(Crawled : 13:00)
- biospace.com/
MRK
|
News
|
$125.78
0.44%
0.0%
8.4M
|
Health Technology
|
0.0%
|
O:
0.5%
H:
0.0%
C:
0.0%
health
treatment
for
canada
advanced
keytruda
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published:
2024-04-19
(Crawled : 02:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
0.0%
|
O:
0.42%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.0%
|
O:
0.82%
H:
0.0%
C:
0.0%
MIRM
|
News
|
$23.83
1.1%
1.09%
340K
|
Health Technology
|
0.0%
|
O:
1.42%
H:
0.0%
C:
0.0%
report
million
reach
treatment
market
California Water Service Group Moving Forward to Install PFAS Treatment Despite CPUC Dismissal of Request to Track Capital Costs in Pre-Approved Memorandum Account
Published:
2024-04-18
(Crawled : 21:00)
- globenewswire.com
CWT
|
$45.79
1.98%
0.0%
710K
|
Utilities
|
Email alert
Add to watchlist
water
california
service
group
treatment
European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
MBRX
|
$4.65
2.8%
2.72%
11K
|
Health Technology
|
5.61%
|
O:
4.91%
H:
11.36%
C:
0.67%
drug
treatment
designation
for
grants
leukemia
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published:
2024-04-18
(Crawled : 13:00)
- globenewswire.com
ONCT
|
$8.97
4.3%
4.12%
4.5K
|
Health Technology
|
Email alert
Add to watchlist
onct-534
first
cancer
treatment
for
study
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
Published:
2024-04-17
(Crawled : 22:00)
- biospace.com/
DMAC
|
$2.46
-1.21%
-1.22%
21K
|
Health Technology
|
4.43%
|
O:
4.43%
H:
0.0%
C:
0.0%
dm199
first
stroke
treatment
for
trial
therapeutics
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published:
2024-04-17
(Crawled : 13:00)
- globenewswire.com
ABVC
|
$0.9899
-5.72%
-6.07%
160K
|
Wholesale Trade
|
-10.71%
|
O:
2.68%
H:
3.48%
C:
-11.3%
treatment
biopharma
royalties
global
for
agreement
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published:
2024-04-17
(Crawled : 12:00)
- prnewswire.com
NRBO
|
$3.325
-3.34%
-3.46%
21K
|
Health Technology
|
1.76%
|
O:
8.53%
H:
0.0%
C:
-6.23%
da-1726
obesity
first
treatment
pharmaceuticals
for
trial
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
GENE
1 d
|
$2.27
-6.97%
-7.49%
64K
|
Health Technology
|
-23.03%
|
O:
3.47%
H:
0.0%
C:
-3.66%
precision
treatment
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
CMND
|
$1.22
3.56%
3.43%
110K
|
n/a
|
-0.82%
|
O:
-0.82%
H:
0.0%
C:
0.0%
disorders
treatment
for
agreement
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
Published:
2024-04-17
(Crawled : 12:00)
- biospace.com/
SAGE
|
$13.35
2.42%
2.36%
1.3M
|
Health Technology
|
-17.57%
|
O:
-15.02%
H:
3.55%
C:
-3.01%
sage-718
disease
treatment
topline
parkinson’s
therapeutics
results
study
Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published:
2024-04-17
(Crawled : 09:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.63%
|
O:
0.12%
H:
0.51%
C:
0.51%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-0.08%
|
O:
-0.04%
H:
0.28%
C:
-0.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.78%
|
O:
1.05%
H:
0.0%
C:
0.0%
treatment
global
growth
market
Fracking Water Treatment Market size to record USD 1.20 billion growth from 2023-2027, Adoption of supercritical carbon in fracking is one of the key market trends, Technavio
Published:
2024-04-16
(Crawled : 23:00)
- prnewswire.com
XYL
|
$127.84
0.53%
0.0%
2.2M
|
Producer Manufacturing
|
-1.39%
|
O:
0.38%
H:
0.0%
C:
-1.77%
water
one
treatment
key
growth
market
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
Published:
2024-04-16
(Crawled : 20:00)
- globenewswire.com
CLNN
S
|
$0.3492
5.85%
5.53%
1.2M
|
|
Email alert
Add to watchlist
au8
neurology
sclerosis
treatment
for
meeting
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Published:
2024-04-16
(Crawled : 16:00)
- biospace.com/
BBIO
|
$24.74
-0.84%
-0.85%
2M
|
Health Technology
|
-3.18%
|
O:
-1.47%
H:
2.05%
C:
-0.59%
nulibry
authorization
treatment
for
therapeutics
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-1.77%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
$19.98
0.0%
540K
|
Health Technology
|
-2.52%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.82
-1.74%
-1.83%
640K
|
Health Technology
|
1.9%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
LXEO
|
$11.995
-0.62%
-0.63%
87K
|
|
2.81%
|
O:
5.32%
H:
0.0%
C:
-2.63%
lx2006
fda
candidate
granted
treatment
designation
for
therapeutics
therapy
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Published:
2024-04-15
(Crawled : 21:00)
- globenewswire.com
ZVRA
|
$4.515
0.33%
0.33%
360K
|
n/a
|
-3.03%
|
O:
1.15%
H:
1.03%
C:
-1.45%
disease
treatment
for
meeting
therapeutics
Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose
Published:
2024-04-15
(Crawled : 20:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.16%
|
O:
-2.09%
H:
0.0%
C:
0.0%
opioid
million
treatment
for
← Previous
1
2
3
4
5
6
7
8
9
…
22
23
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.